期刊文献+

survivin、Ki-67在胃肠间质瘤中的表达及其相互关系 被引量:2

Expression of survivin and Ki-67 in gastrointestinal stromal tumors and its clinical implication
下载PDF
导出
摘要 目的:探讨survivin蛋白、增殖相关抗原Ki-67在不同恶性度胃肠间质瘤(GIST)中的表达及意义。方法:采用免疫组化SP法检测78例胃肠道间质瘤组织中survivin、Ki-67蛋白的表达,并分析其在不同性质的GIST中的表达差异。结果:78例GIST中,survivn、Ki-67蛋白的阳性表达率分别为69.2%和38.5%。Ki-67在胃肠间质瘤组中的表达高于在正常对照组中的表达,survivin,Ki-67蛋白在低度恶性、中高度恶性的GIST中的表达有显著差异(P<0.05)。在GIST肿瘤组织中survivin与Ki-67表达强度具有显著的正相关(rs'=0.57)。结论:survivin和Ki-67可能协同作用于GIST的发生发展,surivin和Ki-67蛋白对判断GIST的性质具有重要意义。 Objective: To investigate the expression of survivin and Ki-67 protein in gastrointestinal stromal tumors(GIST) and its clinical significance.Methods: The expression of survivin and Ki-67 protein were detected in 78 cases of GIST by immunohistochemical technique.The relationship between expression of survivin and Ki-67 protein and the clinicopathological factors of GIST was analyzed.Results: The positive expression rates of survivin and Ki-67 protein in GIST were 69.2% and 38.5% respectively,the difference of positive expression rate of survivin and Ki-67 protein was significant among benign,borderline and malignant GISTs(P 0.05).There was significant correlation between survivin and Ki-67(rs′= 0.57).Conclusion: Survivin and Ki-67 may play synergistic effect in the pathogenesis of GIST.The expression of survivin and Ki-67 protein are important predicting markers for differentiation degree of GIST.
作者 宋国庆 王强
出处 《现代肿瘤医学》 CAS 2012年第12期2560-2562,共3页 Journal of Modern Oncology
关键词 SURVIVIN KI-67 胃肠间质瘤 免疫组织化学 survivin Ki-67 gastrointestinal stromal tumor immunohistochemistry
  • 相关文献

参考文献12

  • 1Baykara M, Akkus M,Yildiz R,et al. Survivin expression and itspotential clinical significance in gastrointestinal stromal sarcoma[J]. lnt Immunopharmacol, 2011,10: 20,.
  • 2Gunji Y,Nikaidou T,Okazumi S, et al. Evaluation of Ki -67 andp53 expression in primary and repeated liver metastases of GISTs[J]. Hepatogastroenterology, 2005 ,52(63) : 829 -832.
  • 3Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastroin-testinal stromal tumors: a consensus approach [ J]. Hum Pathol,2002,33(5):459 - 465.
  • 4Ambrosini G, Adida C, Altieri DC. A novel anti - apoptosis gene,Survivin, expressed in cancer and lymphoma[ J]. Nat Med, 1997,3: 917.
  • 5Ito T, Shiraki K, Sugimoto K,et al. Survivin promotes cell prolif-eration in human hepatocellular carcinomaf J] . Hepatology, 2000,31: 1080.
  • 6Tamm I,Wang Y, Sausville E, et al. IAP - family protein Sur-vivin inhibits caspase activity and apoptosis induced by Fas(CD95),Bax, caspases,and anticancer drugs[ J]. Cancer Res,1998, 58: 5315.
  • 7Altieri DC,Marchisio PC,Marchisio C. Survivin apoptosis: an in-terloper between cell death and cell proliferation in cancer[ J]. LabInvest, 1999,79: 1327.
  • 8Adida C,Crotty PL, Me Grath J, et al. Developmentally regulatedexpression of the novel cancer anti - apoptosis gene Survivin in hu-man and mouse differentiation[ J]. Am J Pathol, 1998, 152 : 43.
  • 9Emory TS, Sob IN LH. Prognosis of gastointestinal smooth muscle(stromal) tumors: Dependence on anatomic site [ J] . Am J SurgPathol, 1999, 23(1): 821.
  • 10Gerdes J, Schwab U, Lemke H, et al. Production of a mousemoneclonal antibody relative with a human nuclear antigen as so-ciated with cell proliferation[J]..lnt J Cancer, 1983,31 (1):13.

同被引文献29

  • 1Tsung-Hui Hu,Seng-Kee Chuah,Jui-Wei Lin,Yi-Chun Chiu,Chi-Sin Changchien,Chih-Chi Wang,Yaw-Sen Chen,Li-Na Yi,King-Wah Chiu,Chuan-Mo Lee.Expression and prognostic role of molecular markers in 99 KIT-positive gastric stromal tumors in Taiwan Residents[J].World Journal of Gastroenterology,2006,12(4):595-602. 被引量:1
  • 2Lebe B,Sagol 0,Ulukus C, et al. The importance of cyclin D1 andKi - 67 expression on the biological behavior of pancreatic adeno-carcinomas [ J ]. Pathol Res Pract ,2004,200 (5) :389-396.
  • 3Beadling C,Patterson Jt Justusson E,et al. Gene expression of theIGF pathway family distinguishes subsets of gastrointestinal stromaltumors wild type for KIT and PDGFRA[ J]. Cancer Med,2013,2;21 -31.
  • 4Beham AW,Schaefer IM,Schuler P,et al. Gastrointestinal stromal-tumors[ J] . Int J Colorectal Dis, 2012,27(6) : 689 -700.
  • 5Chandrasekhara Y, Ginsberg GG. Endoscopic management of gas-trointestinal stromal tumors[ J]. Curr Gastroenterol Rep,2011,13:532 -539.
  • 6Fiilo PE,Maxcu S,Borda A,et al. Histopathological and immuno-histochemical featmes of gastrointestinal stromal tumors[ J]. Rom JMorphol Embryol,2011,52:555 -562.
  • 7Tzen CY, Wang JH,Huang YJ,et al. Incidence of gastrointestinalstromal tumor: A retrospective study based on immunohistochemicaland mutational analyses[ J] . Dig Dis Sci ,2007,52(3) ;792 -797.
  • 8Wang C,Jin MS,Zou YB,et al. Diagnostic significance of DOG - 1and PKC - 0 expression and c - Kit/PDGFRA mutations in gastro-intestinal stromal tumours [ J ]. Scand J Gastroenterol, 2013 , 48 :1055 -1065.
  • 9Demetri GD,von Mehren M, Antonescu CR,et al. NCCN task forcereport : update on the management of patients with gastrointestinalstromal tumors[ J]. Natl Compr Cane Netw,2010,8 :S1 - S41.
  • 10Corless CL,Heinrich MC. Molecular pathobiology of gastrointestinalstromal sarcomas[ J]. Annu Rev Pathol,2008,3 :557 -586.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部